178 related articles for article (PubMed ID: 21063505)
1. Yin and Yang Part Deux: CCN5 inhibits the pro-fibrotic effects of CCN2.
Leask A
J Cell Commun Signal; 2010 Oct; 4(3):155-6. PubMed ID: 21063505
[TBL] [Abstract][Full Text] [Related]
2. The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Yoon PO; Lee MA; Cha H; Jeong MH; Kim J; Jang SP; Choi BY; Jeong D; Yang DK; Hajjar RJ; Park WJ
J Mol Cell Cardiol; 2010 Aug; 49(2):294-303. PubMed ID: 20430035
[TBL] [Abstract][Full Text] [Related]
3. Yin and Yang: CCN3 inhibits the pro-fibrotic effects of CCN2.
Leask A
J Cell Commun Signal; 2009 Jun; 3(2):161-2. PubMed ID: 19475498
[TBL] [Abstract][Full Text] [Related]
4. The carboxyl-terminal TSP1-homology domain is the biologically active effector peptide of matricellular protein CCN5 that counteracts profibrotic CCN2.
Zolfaghari S; Kaasbøll OJ; Monsen VT; Sredic B; Hagelin EMV; Attramadal H
J Biol Chem; 2023 Jan; 299(1):102803. PubMed ID: 36529291
[TBL] [Abstract][Full Text] [Related]
5. CCN5 attenuates profibrotic phenotypes of fibroblasts through the Smad6-CCN2 pathway: Potential role in epidural fibrosis.
Xu H; Liu C; Sun Z; Guo X; Zhang Y; Liu M; Li P
Int J Mol Med; 2015 Jul; 36(1):123-9. PubMed ID: 25901787
[TBL] [Abstract][Full Text] [Related]
6. Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2).
Butler GS; Connor AR; Sounni NE; Eckhard U; Morrison CJ; Noël A; Overall CM
Matrix Biol; 2017 May; 59():23-38. PubMed ID: 27471094
[TBL] [Abstract][Full Text] [Related]
7. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
8. Expression and biological function of the cellular communication network factor 5 (CCN5) in primary liver cells.
Borkham-Kamphorst E; Meurer SK; Weiskirchen R
J Cell Commun Signal; 2023 Jun; 17(2):307-320. PubMed ID: 37166689
[TBL] [Abstract][Full Text] [Related]
9. Role of CCN5 (WNT1 inducible signaling pathway protein 2) in pancreatic islets.
Liu JL; Kaddour N; Chowdhury S; Li Q; Gao ZH
J Diabetes; 2017 May; 9(5):462-474. PubMed ID: 27863006
[TBL] [Abstract][Full Text] [Related]
10. CCN2 and CCN5 exerts opposing effect on fibroblast proliferation and transdifferentiation induced by TGF-β.
Xu H; Li P; Liu M; Liu C; Sun Z; Guo X; Zhang Y
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1207-19. PubMed ID: 26218313
[TBL] [Abstract][Full Text] [Related]
11. CCN2 is required for recruitment of Sox2-expressing cells during cutaneous tissue repair.
Tsang M; Leask A
J Cell Commun Signal; 2015 Dec; 9(4):341-6. PubMed ID: 25326099
[TBL] [Abstract][Full Text] [Related]
12. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
13. Driving fibrosis in neuromuscular diseases: Role and regulation of Connective tissue growth factor (CCN2/CTGF).
Rebolledo DL; Lipson KE; Brandan E
Matrix Biol Plus; 2021 Aug; 11():100059. PubMed ID: 34435178
[TBL] [Abstract][Full Text] [Related]
14. Molecular and Genetic Interactions between CCN2 and CCN3 behind Their Yin-Yang Collaboration.
Kubota S; Kawata K; Hattori T; Nishida T
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682564
[TBL] [Abstract][Full Text] [Related]
15. CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins.
Heng EC; Huang Y; Black SA; Trackman PC
J Cell Biochem; 2006 May; 98(2):409-20. PubMed ID: 16440322
[TBL] [Abstract][Full Text] [Related]
16. CCN5 Expression in mammals. II. Adult rodent tissues.
Gray MR; Malmquist JA; Sullivan M; Blea M; Castellot JJ
J Cell Commun Signal; 2007 Sep; 1(2):145-58. PubMed ID: 18481204
[TBL] [Abstract][Full Text] [Related]
17. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
18. N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan.
Aoyama E; Hattori T; Hoshijima M; Araki D; Nishida T; Kubota S; Takigawa M
Biochem J; 2009 May; 420(3):413-20. PubMed ID: 19298220
[TBL] [Abstract][Full Text] [Related]
19. Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.
Wu Q; Jorgensen M; Song J; Zhou J; Liu C; Pi L
Gastroenterol Res Pract; 2016; 2016():2313850. PubMed ID: 27829832
[TBL] [Abstract][Full Text] [Related]
20. Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis.
Kantarci A; Black SA; Xydas CE; Murawel P; Uchida Y; Yucekal-Tuncer B; Atilla G; Emingil G; Uzel MI; Lee A; Firatli E; Sheff M; Hasturk H; Van Dyke TE; Trackman PC
J Pathol; 2006 Sep; 210(1):59-66. PubMed ID: 16841303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
